TEST MENU Table 92023.xlsx
XLSX spreadsheet 243 KB Posted
- Attached to
- Q301--VISN Bridge BPA
- Solicitation number
- 36C25623Q1985
About this file
This document provides details of a federal contract opportunity with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16. The solicitation is for a blanket purchase agreement to provide laboratory information and testing services to participating VA medical centers and outpatient clinics within VISN 16. Services include routine and specialized clinical pathology and anatomic pathology testing, with an estimated annual testing volume of over 3 million procedures. The agreement will have a one-year base period and four one-year options to extend. Pricing will be negotiated between contractors and individual medical facilities based on established Medicare and other commercial rates.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C25623Q1985.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Lab Info
| VISN 16 Participating Laboratories Referral Laboratory Testing Services | |
| Facility Name | Lab Location/Pick-Up Address |
| VAMC Laboratories | |
| Alexandria VAMC | |
| 2495 Shreveport Hwy 71N, Bldg 7, Laboratory 3rd floor, Rm 350 |
Pineville, LA 71360
| Gulf Coast Veterans Healthcare System (Biloxi) |
| 400 Veterans Blvd |
Bld 3, 3 floor, 3B 111 Biloxi, MS 39531
| Veterans Health Care System of the Ozarks (Fayetteville) |
| 1100 N. College Ave. |
Bldg 21 Room 3100 Fayetteville, AR 72703
| Michael E DeBakey VA Medical Center (Houston) |
| 2002 Holcombe Blvd. |
Room 3A-120 Houston, TX 77030
| Jackson VAMC |
| P&LMS (113) |
1500 E. Woodrow Wilson Room F-28 Jackson, MS 39216
| Central Arkansas Veterans Healthcare System (CAVHS-Little Rock) |
| 4300 West 7th St. Room 2D-171 Little Rock, AR 72205 |
| SLVHCS New Orleans |
2400 Canal Street Room 4E122 New Orleans, LA. 70119
| Overton Brooks VAMC (Shreveport) |
| 510 E Stoner Avenue |
Room 2E 6 Shreveport, LA 71101 Outpatient Clinic Laboratories
SLVHCS Baton Rouge OPC 7850 Anselmo Lane Room 101 Baton Rouge LA 70801-7439
Eglin Outpatient Clinic 100 Veterans Way, Room 158 Eglin AFB,FL 32542 Mobile Outpatient Clinic 4444 Demetroplois Road Room 1C120 Mobile AL,36619-9602 Panama City Outpatient Clinic 2600 Veterans Way Room 1B128 Lab Panama City Beach, FL 32408-7186
| Joint Ambulatory Care Center (JACC) (Pensacola) |
| 790 Veterans Way |
Lab Foxtrot Section Room 1D-110 Pensacola, FL 32507
V16 Test Menu
| CPT Code | V16 TEST NAME | Annual Estimated VISN 16 Volume |
| 86316 | Neuron Specific Enolase, CSF | 2 |
| 82607, 82746 | Vitamin B12 and Folate | 1 |
| 84550 | Uric Acid, Serum | 1 |
| 84450 | AST (SGOT) | 1 |
| 84436 | Thyroxine (T4) | 1200 |
| 84479 | T3 Uptake | 40 |
| 84478 | Triglycerides | 2 |
| 82247, 82248 | Bilirubin, Total and Bilirubin, Direct, Serum | 10 |
| 82248 | Bilirubin, Direct | 5 |
| 83540, 83550 | Iron and TIBC | 1 |
| 82710 | Fecal Fat, Quantitative | 10 |
| 82550 | Creatine Kinase,Total | 1 |
| 84157, 84166, 86335 | Immunofixation (IFE) and Protein Electrophoresis, CSF | 3 |
| 83036 | Hemoglobin A1C IFCC and DCCT traceable and no interference from HbF, HbE, HbC, HbD |
Gentry, Holly C (V16): Gentry, Holly C (V16):
routine A1c analysis performed by VA labs using HPLC prior to requesting this send out A1C. Test shall have no interference from HbF, HbE, HbC, HbD required for send out follow-up. Method shall be traceable to IFCC reference method and NGSP traceable to DCCT study
| 2178 | ||
| 82784(3), 86334 | Immunofixation Reflex, Serum | 311 |
| 82607 | Vitamin B12 | 4 |
| 82380 | Carotene, Beta | 10 |
| 82390 | Ceruloplasmin | 30 |
| 82525 | Copper, Serum and Plasma | 950 |
| 82595 | Cryoglobulin, Qual, Serum, Reflex to Quant. | 75 |
| 85384 | Fibrinogen Activity | 1 |
| 84080, 84075 | Alk Phos Isoenzyme | 245 |
| 83010 | Haptoglobin | 7 |
| 82705 | Fecal Fat, Qualitative | 450 |
| 82784(3), 86334 | Immunofixation (IFE) Serum | 10 |
| 86334 | Immunofixation Elect inpretation if monoclonal heavy and light-chain patterns are present | 4 |
| 83915 | 5' Nucleotidase | 49 |
| 84442 | Thyroxine Binding Globulin | 80 |
| 82784(3) | Immunoglobulins A/G/M, Qn, Serum | 3 |
| 84630 | Zinc, Plasma and Serum | 1300 |
| 82180 | Vitamin C | 131 |
| 86160 | Complement C4, Serum | 1 |
| 83625, 83615 | LD Isoenzymes | 6 |
| 82955, 85041 | G-6-PD, Quant, Blood and Red Blood Cell Count | 287 |
| 86162 | Complement, Total (CH50) | 155 |
| 85540 | Leukocyte Alkaline Phos Score | 120 |
| 84439 | Thyroxine (T4) Free, Direct, Serum and plasma | 10 |
| 82103 | Alpha-1-Antitrypsin, Serum | 1100 |
| 84244 | Renin Activity, Plasma | 1850 |
| 82746 | Folate, Serum | 1 |
| 82085 | Aldolase | 700 |
| 82945 | Glucose, Cerebrospinal Fluid | 8 |
| 84157 | Protein, Total, Cerebrospinal Fluid | 8 |
| 82438 | Chloride, Cerebrospinal Fluid | 8 |
| 83930 | Osmolality, serum; plasma | 800 |
| 82378 | Carcinoembryonic Antigen (CEA) | 224 |
| 82550, 82552 | CK, Total+Isoenzymes, Serum | 165 |
| 82784 | Immunoglobulin D, Quant, Serum | 42 |
| 82785 | Immunoglobulin E, Total | 1825 |
| 84480 | Triiodothyronine (T3) | 922 |
| 82042, 82784(2), 82040 | Immunoglobulin G Index | 2 |
| 84157, 84166 | Protein Electrophoresis, CSF | 8 |
| 82105 | Alpha-Fetoprotein (AFP) | 1 |
| 86301 | CA (Carbohydrate Antigen )19-9 | 219 |
| 86304 | Cancer Antigen (CA) 125 | 59 |
| 82550, 82553 | Creatine Kinase (CK), MB and Total | 1 |
| 82540 | Creatine, Serum | 1 |
| 82575 | Creatinine Clearance | 1 |
| 81003 | Urinalysis, Routine | 2 |
| 84110 | Porphobilinogen, Qn, Random Urine | 22 |
| 83874 | Myoglobin, Urine | 60 |
| 84110 | Porphobilinogen, Qn, 24-Hr Urine | 15 |
| 82570, 84156 | Protein and Creatinine, Random Urine | 50 |
| 82438 | Chloride, 24 hour Urine | 1 |
| 84120 | Porphyrins, Quant, 24 Hr Urine |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| includes coproporphyrins I and III; uroporphyrins; heptacarboxylporphyrins; hexacarboxylporphyrins; pentacarboxylporphyrins; | 16 | ||
| 84105 | Phosphorus, 24 hr Urine | 30 | |
| 82340 | Calcium, 24Hr Urine | 59 | |
| 84156 | Protein,Total,Urine | 5 | |
| 82150 | Amylase, Urine | 2 | |
| 82525, 82570 | Copper, Urine | 50 | |
| 82945 | Glucose, Quantitative, Urine | 2 | |
| 83735 | Magnesium, Urine | 38 | |
| 84560 | Uric Acid, 24 hr Urine | 45 | |
| 84630, 82570 | Zinc, Urine | 2 | |
| 83935 | Osmolality, Urine | 800 | |
| 84540 | Urea Nitrogen, 24-Hour Urine | 5 | |
| 84166, 84156 | Protein Electrophoresis Random Urine (with Reflex to IFE) | 10 | |
| 81001 | Urinalysis, Complete w/microscopic exam | 1 | |
| 83945 | Oxalate, Quant, 24-Hour Urine | 175 | |
| 82627 | Dehydroepiandrosterone (DHEA ) Sulfate, Serum | 625 | |
| 82570, 83835 | Metanephrines, Pheochromocytoma random urine | 20 | |
| 82533 | Cortisol | 335 | |
| 83497 | 5-HIAA,Quant.,24 Hr Urine | 100 | |
| 82626 | DHEA Serum | 125 | |
| 84585 | Vanillylmandelic Acid, 24-Hr U | 25 | |
| 82384 | Catecholamines,Urinary Free,24 Hr | 127 | |
| 83520 | NMO IgG Autoantibodies | 64 | |
| 84403 | Testosterone, Total Serum | 2 | |
| 83835 | Metanephrines, Frac, Qn, 24-Hr | 240 | |
| 84443 | TSH | 1 | |
| 83003 | Growth Hormone, Serum | 212 | |
| 83520 | Tryptase | 169 | |
| 83002 | Luteinizing Hormone(LH) | 1 | |
| 82088 | Aldosterone, Urine 24 hour | 51 | |
| 83001 | FSH serum and plasma | 1 | |
| 84144 | Progesterone | 450 | |
| 83525 | Insulin | 1150 | |
| 82088, 84244 | Aldosterone/Renin Ratio Serum, plasma | 50 | |
| 82088 | Aldosterone, LCMS Serum, plasma | 1850 | |
| 83520 | Fibroblast Growth Factor 23 (FGF-23) | 4 | |
| 82941 | Gastrin, Serum | 156 | |
| 84702 | hCG,Beta Subunit, Qnt, Serum | 91 | |
| 82530 | Cortisol, Urinary Free | 200 | |
| 82024 | ACTH, Plasma | 1550 | |
| 84146 | Prolactin serum; plasma | 1 | |
| 84146 (x2) | Prolactin Macroadenoma | 2 | |
| 82670 | Estradiol | 1300 | |
| 82672 | Estrogens, Total | 600 | |
| 84703 | hCG,Beta Subunit, Qual | 1 | |
| 82679 | Estrone, Serum | 23 | |
| 82728 | Ferritin, Serum | 1 | |
| 82677 | Estriol, Serum | 42 | |
| 82943 | Glucagon, Plasma | 16 | |
| 86160 | C1 Esterase Inhibitor, Serum | 45 | |
| 84207 | Vitamin B6 Plasma | 2150 | |
| 82157 | Androstenedione LCMS-MS | 30 | |
| 84066 | Prostatic Acid Phos, Serum | 14 | |
| 83605 | Lactic Acid, Plasma | 1 | |
| 84210 | Pyruvic Acid, Blood | 3 | |
| 82330 | Calcium, Ionized, Serum | 550 | |
| 85810 | Viscosity, Serum | 20 | |
| 82308 | Calcitonin, Serum | 220 | |
| 83520 | Mannose Binding Lectin (MBL) | 1 | |
| 82030, 82570 | Cyclic AMP, Urine | 5 | |
| 84466 | Transferrin | 5 | |
| 85025 | CBC With Differential/Platelet | 3 | |
| 85014 | Hematocrit | 1 | |
| 85610 | Prothrombin Time (PT) | 77 | |
| 85730 | PTT, Activated | 130 | |
| 85652 | Sedimentation Rate-Westergren | 5 | |
| 85660 | Hgb Solubility | 9 | |
| 89051, 89060 | Cell Count, Synovial w/Crystals | 1 | |
| 89051 | Cell Count, Serous Fluid | 1 | |
| 89051 | Cell Count, CSF | 1 | |
| 85045 | Reticulocyte Count | 5 | |
| 85660 | HB Solubility + Reflex to Hb fractionation cascade | 5 | |
| 89060 | Crystal,Synovial/Joint Fluid | 3 | |
| 83051 | Hemoglobin, Free, Plasma | 40 | |
| 86850 | Antibody Screen (red cell antibody screening) | 10 | |
| 86592 | RPR w/reflex to TrepSure (Tpalladium screening cascade) | 5 | |
| 86060 | Antistreptolysin O Ab | 35 | |
| 86900, 86901 | ABO Grouping and Rho(D) Typing | 30 | |
| 86900 | ABO Grouping | 1 | |
| 86592 | RPR | 1 | |
| 86308 | Mononucleosis Test, Qual | 44 | |
| 86762 | Rubella Antibodies, IgG | 150 | |
| 86880 | Coombs', Direct | 5 | |
| 86235(2) | Antiextractable Nuclear Ag | 550 | |
| 86157 | Cold Agglutinin Titer, Quant | 12 | |
| 86780 | T pallidum Ab (FTA-Ab) | 45 | |
| 86706 | Hep B Surface Ab | 4 | |
| 86592 | VDRL, CSF | 80 | |
| 86160 | Complement C3, Serum | 1 | |
| 86593 | Rapid Plasma Reagin, Quant | 30 | |
| 86777 | Toxoplasma gondii Ab, IgG, Qn | 140 | |
| 83516 | Antiparietal Cell Antibody (APCA) | 160 | |
| 86644 | Cytomegalovirus (CMV) Ab, IgG | 700 | |
| 86431 | Rheumatoid Arthritis Factor | 5100 | |
| 87340 | HBsAg Screen | 30 | |
| 86317 | Hepatitis B Surf Ab Quant | 48 | |
| 86308 | Mononucleosis Test, Qual W/Reflex to Quant Titer | 5 | |
| 87350 | Hep Be Ag | 692 | |
| 86140 | C-Reactive Protein, Quant. | 375 | |
| 86707 | Hep Be Ab | 587 | |
| 83516 | Actin (Smooth Muscle) Antibody | 1150 | |
| 83516 | Mitochondrial (M2) Antibody | 1115 | |
| 86376 | Thyroid Peroxidase (TPO) Ab | 1316 | |
| 86376, 86800 | Thyroid Antibodies | 10 | |
| 86800 | Antithyroglobulin (Thyroglobulin Ab) | 245 | |
| 86800 | Thyroglobulin by IMA | 796 | |
| 86704 | Hep B Core Ab, Tot | 10 | |
| 86708 | Hep A Ab, Total | 1 | |
| 86709 | Hep A Ab, IgM | 5 | |
| 83872 | Mucin Clot,Synovial Fluid | 1 | |
| 87425 | Rotavirus Ag, EIA | 1 | |
| 86753 | Amebiasis Antibodies | 20 | |
| 87802, 87899(3) | Bacterial Antigens (serum) | 4 | |
| 81374 | HLA B 27 Disease Association | 799 | |
| 81381 | HLA B5701 Test | 93 | |
| 82570, 83921 | Orotic Acid, Urine | 1 | |
| 80339 | Lacosamide | 38 | |
| 80176 | Lidocaine (Xylocaine), Serum | 7 | |
| 80179, 80184, 80320, 80345, 80346 | Drug Screen (Blood and Serum) | 1 | |
| 82175, 82570 | Arsenic Exposure Profile, Ur 24 hr with reflex to Arsenic, Toxic species |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| As, creatinine, per 24 hr and ratio, As reflex to Arsenic toxic species | 2 | |
| 82175, 82570, 83655, 83825 | Heavy Metals Profile I, Urine 24 hr with reflex to Arssnic, toxic species |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| creatinine, Pb, Hg, As, per 24 hr and ratios, As (total) relfex to As, toxic species | 68 | ||
| 83050 | Methemoglobin, Blood | 1 | |
| 82140 | Ammonia, Plasma | 50 | |
| 80320 | Volatiles, Blood | 3 | |
| 87467 | HBsAg Quantitative, Monitor | 10 | |
| 80200 | Tobramycin Peak, Serum | 1 | |
| 80200 | Tobramycin Trough, Serum | 1 | |
| 80170 | Gentamicin Peak, Serum | 1 | |
| 80170 | Gentamicin Trough, Serum | 1 | |
| 82375 | Carbon Monoxide (Carboxyhemoglobin) WB | 15 | |
| 80150 | Amikacin Random, Serum | 70 | |
| 80150 | Amikacin Trough, Serum | 15 | |
| 82480 | Cholinesterase, Serum | 4 | |
| 80307 | Ethanol, Urine with confirmation | 1 | |
| 82175 | Arsenic, Blood ICP/MS | 39 | |
| 80192 | Procainamide, Serum | 10 | |
| 80164 | Valproic Acid (Depakote),Serum | 4 | |
| 82482 | Cholinesterase, RBC | 5 | |
| 80198 | Theophylline, Serum and plasma | 25 | |
| 82135 | ALA Delta, Random Urine | 2 | |
| 80182 | Nortriptyline (Aventyl), Serum | 60 | |
| 80185 | Phenytoin (Dilantin), Serum and plasma | 55 | |
| 80156 | Carbamazepine(Tegretol),Serum and plasma | 55 | |
| 83516 | Soluble Liver Ag (IgG Ab) | 6 | |
| 80168 | Ethosuximide (Zarontin), Serum | 1 | |
| 80335 | Imipramine (Tofranil), Serum | 8 | |
| 80335 | Amitriptyline (Elavil), Serum | 53 | |
| 80362 | Meperidine (Demerol), Serum TDM | 1 | |
| 80335 | Doxepin (Sinequan), Serum | 10 | |
| 83655 | Lead, Blood (Adult) | 300 | |
| 82570, 83655 | Lead, Urine | 2 | |
| 80299 | Methotrexate (MTX), Serum | 8 | |
| 80299 | Chlordiazepoxide, Serum | 4 | |
| 80337 | Tricyclic Antidepressants Screen, Serum | 5 | |
| 82978 | Glutathione, Total WB | 1 | |
| 80178 | Lithium (Eskalith), Serum | 85 | |
| 80329 | Acetaminophen (Tylenol), S | 30 | |
| 80335 | Desipramine, Serum | 4 | |
| 82570, 83825 | Mercury, Urine | 2 | |
| 80358 | Methadone (Dolophine), Serum | 50 | |
| 80184 | Phenobarbital, Serum | 13 | |
| 80194 | Quinidine, Serum | 7 | |
| 80329 | Salicylate, Serum | 20 | |
| 80184, 80188 | Primidone (Mysoline), Serum | 20 | |
| 80299 | Disopyramide, Serum | 1 | |
| 80203 | Zonisamide(Zonegran), Serum | 43 | |
| 80299 | Diazepam (Valium), Serum | 3 | |
| 87070, 87075 | Anaerobic and Aerobic Culture | 20 | |
| 87076 | Urine Culture,Comprehensive | 4000 | |
| 87081 | GC Culture Only | 1 | |
| 87206 | Fungus Stain | 16 | |
| 87045, 87046, 87427 | Stool Culture | 1000 | |
| 87207 | Parasite Exam, Blood | 20 | |
| 87252, 87254 | Cytomegalovirus (CMV) Culture | 3 | |
| 87169 | Parasite, ID, worm | 5 | |
| 87255 | HSV Culture and Typing | 55 | |
| 87040 | Blood Culture, Routine | 15 | |
| 87070 | Genital Culture, Routine | 5 | |
| 87070 | Upper Respiratory Culture | 17 | |
| 87107 | Organism Identification, Mold | 35 | |
| 87101 | Fungus (Mycology) Culture | 2619 | |
| 87205 | Gram Stain | 50 | |
| 87110, 87140 | Chlamydia trachomatis Culture | 4 | |
| 87252 | Viral Culture, General | 90 | |
| 89190 | Eosinophil Count, Nasal | 2 | |
| 87177, 87209 | Ova + Parasite Exam Stool and sputum | 950 | |
| 87177 | Ova + Parasite Exam, Urine | 5 | |
| 87070 | Aerobic Bacterial Culture | 100 | |
| 89055 | White Blood Cells (WBC), Stool | 120 | |
| 87077 | Organism ID, Bacteria | 17 | |
| 87186 | Susceptibility, Aer + Anaerob | 84 | |
| 87070 | AFB ID by DNA Probe Reflex AST | 48 | |
| 87086 | Urine Culture, Routine | 15 | |
| 87075 | Anaerobic Culture | 21 | |
| 88173 | Fine-Needle Aspiration | 15 | |
| 88112 | Bronchial Washings Cytology | 3 | |
| 88112 | Pleural Fluid Cytology | 8 | |
| 88112 | Abdominal Fluid Cytology | 1 | |
| 88112 | Urine Cytology | 16 | |
| 88108 | Sputum Cytology | 3 | |
| 88161 | Breast Discharge Cytology | 1 | |
| 88112 | Miscellaneous Fluid Cytology | 5 | |
| 88112 | Anal(Rectal) Cytology, Liquid Based Prep (LBP) | 35 | |
| 88104 | Bronchial Brushings | 5 | |
| 84681 | C-Peptide, Serum | 2768 | |
| 82164 | Angiotensin-Converting Enzyme | 600 | |
| 84202 | Protoporphyrin, FEP/ZPP | 4 | |
| 84202 | Zinc Protoporphyrin (ZPP) WB | 20 | |
| 82232 | Beta-2 Microglobulin, Urine | 30 | |
| 82232 | Beta-2 Microglobulin, Serum | 653 | |
| 83937 | Osteocalcin, Serum | 15 | |
| 86664 | Epstein-Barr Nuclear Antigen Ab, IgG | 10 | |
| 83520 | Thyrotropin Receptor Ab, Serum | 300 | |
| 84153 | Prostate-Specific Ag (PSA), Serum | 3 | |
| 82239 | Bile Acids | 8 | |
| 83519 | Trypsin | 8 | |
| 84305 | Insulin-like Growth Factor 1 (IGF-1) | 700 | |
| 84481 | Triiodothyronine,Free,Serum | 100 | |
| 84586 | VIP (Vasoactive Intestinal Polypeptide), Plasma | 40 | |
| 83874 | Myoglobin, Serum | 55 | |
| 86340 | Intrinsic Factor Abs, Serum | 230 | |
| 83519 | Melanocyte Stimulating Hormone (MSH) | 2 | |
| 82607 | APCA+ Intrinsic Factor (IF) Ab | 1 | |
| 84588 | Antidiuretic hormone (ADH) Plasma | 22 | |
| 84588 | Copeptin, Plasma | 1 | |
| 86658(7) | Enterovirus Antibodies Profile | 2 | |
| 83986 | pH, Stool | 10 | |
| 83986 | pH, Body Fluid | 35 | |
| 86592 | RPR, Rfx RPR Quant titer and Confirm Treponema (TP) Abs | 3960 | |
| 86593, | RPR Quant +Treponem Abs | 420 | |
| 82784 | Immunoglobulin G, Quant, CSF | 35 | |
| 82042 | Albumin, Cerebrospinal Fluid | 3 | |
| 86235 | Antihistone Antibodies | 106 | |
| 86235 | Antichromatin Antibodies | 10 | |
| 83516 | Antiribosomal P Antibodies | 7 | |
| 86235(2) | Sjogren's Ab, Anti-SS-A/-SS-B | 950 | |
| 84520 | Urea Nitrogen, Urine | 8 | |
| 82570 | Creatinine, Urine (random) | 1 | |
| 86022(4) | Platelet Antibody Profile, Serum |
Gentry, Holly C (V16): Gentry, Holly C (V16):
HLA Class 1 Ab, II/IIIa Ab, Ib/IX Ab, Ia/IIa Ab,
| 1 | ||
| 87807 | RSV Ag, EIA | 3 |
| 85300 | Antithrombin Activity | 85 |
| 85301 | Antithrombin Antigen (immunologic) | 4 |
| 85670 | Thrombin Time | 1 |
| 85300, 85301 | Antithrombin III, Deficiency Profile Func/Immunol | 25 |
| 83970 | PTH, Intact Parathyroid Aspirate | 2 |
| 83970 | PTH, Intact Serum | 1 |
| 86757 | Murine Typhus Antibodies, IgG | 2 |
| 86757 | Rocky Mtn Spotted Fev, IgG, Quant | 240 |
| 86757 | Rocky Mtn Spotted Fever, IgM, Quant | 240 |
| 86638 | Q Fever Antibodies, IgG (phase 1 & phase II) | 25 |
| 86160 | Complement C1q, Quantitative | 20 |
| 82507 | Citric Acid (Citrate), Urine | 180 |
| 82172 | Apolipoprotein A-1 | 12 |
| 86705 | Hep B Core Ab, IgM | 15 |
| 84134 | Prealbumin | 24 |
| 80345 | Pentobarbital | 1 |
| 84590 | Vitamin A, Serum | 365 |
| 82010 | Acetone, blood | 1 |
| 84600 | Isopropanol | 1 |
| 84600 | Methanol | 15 |
| 80320 | Ethanol, Blood | 12 |
| 86235 | Antiscleroderma-70 Antibodies | 193 |
| 83916 | Oligoclonal Banding | 45 |
| 81332, 82103 | A1A Phenotype Confirmation | 4 |
| 82945 | Glucose, Body Fluid | 275 |
| 84560 | Uric Acid, Body Fluid | 2 |
| 84157 | Protein, Body Fluid | 300 |
| 85610, 85730 | PT and PTT | 5 |
| 86644, 86762, 86777, 86694 | Prenat Infect Dis Ab, IgG, Quant | 1 |
| 83655, 84202 | Lead Standard Profile, Blood | 1 |
| 86800 | Thyrogobulin Ab + Thyroglobulin,IMA or LC/MS-MS (serum Thyroglobulin by IMA or LC/MS-MS depending on anti-tg result) | 180 |
| 86800 | Thyroglobulin w/antithyroglobulin (Anti-TG) Ab (serum Thyroglobulin by IMA or RIA depending on anti-tg result) | 800 |
| 82175, 83655, 83825 | Heavy Metals Profile I, Blood (Arsenic, Lead, Mercury) | 300 |
| 82951, 82952 (x2) | Lactose Tolerance Test, enzymatic | 1 |
| 83930, 84588 | Antidiuretic Hormone (ADH) Profile | 30 |
| 86038, 86235 | Scleroderma Diagnostic Profile | 22 |
| 83970 | PTH (C-Terminal) | 1 |
| 86735, 86762, 86765 | Measles/Mumps/Rubella Immunity | 1400 |
| 86003(x13) | Allergen Profile, Mold |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| Alternaria tenuis; Aspergillus fumigatus; Aureobasidium pullulans; Candida albicans; Cladosporium herbarum; Epicoccum purpurascens; Fusarium moniliforme; Helminthosporium halodes; Hormodendrum hordei; Mucor racemosus; Penicillium notatum; Phoma betae; Stemphylium botryosum | 110 | |
| 86003(x13) | Seasonal Allrgns, Fall--Weed |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| Cocklebur; English plantain; goldenrod; kochia (firebush); lamb's quarters; marsh elder, rough; mugwort; pigweed, rough; ragweed, false; ragweed, common/short; lenscale; wormwood/sagebrush; yellow dockweed | 12 | |
| 86003(x19) | Allergens, Perennial |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| Alternaria alternata; Aspergillus fumigatus; Aureobasidium pullulans; Candida albicans; cat dander; chicken feathers; Cladosporium herbarum; cow dander; Dermatofagoides farinae; Dermatofagoides pteronyssinus; dog dander; duck feathers; goose feathers; mouse urine; Mucor racemosus; Penicillium chrysogenum; Phoma betae; Setomelanomma rostrata; Stemphylium herbarum | 1 | |
| 86003(x6) | Allergen Profile, Shellfish |
Gentry, Holly C (V16): Gentry, Holly C (V16):
Clam; crab; lobster; oyster; scallop; shrimp
| 350 | ||
| 86003 | C001-IgE Penicillin G | 1 |
| 86003(x5) | Hymenoptera Profile |
Gentry, Holly C (V16): Gentry, Holly C (V16):
Venoms for: Honeybee; paper wasp; white face hornet; yellow hornet; yellow jacket
| 5 | ||
| 84403 | Testosterone, Women/Child | 1 |
| 80375 | Leflunomide Metabolite (ARAVA) | 1 |
| 84630 | Zinc, whole blood | 12 |
| 83789 | Iodine, Serum/Plasma | 10 |
| 84402, 84403 | Testosterone, Free Equilibrium + Total LC/MS | 4150 |
| 80323 | Nicotine and Metabolite, Urine Quant | 5 |
| 82735 | Fluoride, Serum | 2 |
| 83498 | 17-OH Progesterone LCMS | 100 |
| 84591 | Vitamin B7 serum and plasma | 3 |
| 80348 | Buprenorphine and Metabolite, serum, plasma or WB LC/MS-MS | 11 |
| 84482 | Reverse T3 | 80 |
| 82542 | Vitamin B3 (Niacin+Metabolite) | 25 |
| 86800 | Thyroglobulin by LCMS | 22 |
| 84446 | Vitamin E, Serum | 450 |
| 83789 | Iodine, Urine random | 6 |
| 83789 | Iodine, Urine w/Creat Ratio | 1 |
| 83789 | Iodine, 24 Hour Urine | 9 |
| 82017 | Acylcarnitine Profile, Quantative, Plasma | 3 |
| 84403, 84402 | Testerosterone, Free + Weakly Bound w/Total, LC/MS-MS | 1 |
| 82570, 83498 | 17-OH Progesterone/Creat Ratio, Urine | 1 |
| 80202 | Vancomycin Trough, Serum | 1 |
| 80307, 82570 | Cannabinoids/Creatinine Ratio | 4 |
| 99199 | Chain-of-Custody Protocol | 2 |
| 80173 | Haloperidol (Haldol), Serum | 5 |
| 83498 (X2) | 17-OH Progesterone ACTH Stimulation | 1 |
| 80185, 80186 | Phenytoin,Free and Total,Serum | 1 |
| 80186 | Phenytoin, Free, Serum | 20 |
| 80164 | Free Valproic Acid (Depakote) | 30 |
| 80302 | LSD, Urine | 1 |
| 80323 | Nicotine and Metabolite, Quant | 225 |
| 82542 | Caffeine, Serum | 3 |
| 80324 | Amphetamine Confirmation, GC/MS Urine | 400 |
| 80345 | Barbiturate Confirmation, MS, Urine | 16 |
| 80346 | Benzodiazepine Confirmation,Urine GC/MS Oxazepam, nordiazepam, α-OH-alprazolam | 150 |
| 80349 | Cannabinoid (THC) Confirmation, MS, Urine | 350 |
| 80359 | MDMA Confirmation | 1 |
| 80353 | Cocaine Confirm, MS, Urine | 50 |
| 80361 | Opiate Confirmation, MS, (Codeine/Morphine) | 10 |
| 83992 | Phencyclidine, Confirm, MS Urine | 6 |
| 83018 | Cobalt, plasma | 50 |
| 83018 | Cobalt, Urine | 1 |
| 82495 | Chromium, Plasma | 50 |
| 80361 | Hydrocodone and Metabolite serum, plasma or WB (LC/MS-MS) | 550 |
| 92495, 92570 | Chromium, Urine | 1 |
| 80365 | Oxycodone and Metabolite serum, plasma or WB (LC/MS-MS) | 250 |
| 80354 | Fentanyl and Metabolite, Serum Plasma or WB (LC/MS-MS) | 80 |
| 80299 | Tramadol Serum Plasma or WB (LC/MS-MS) | 3 |
| 82108 | Aluminum, Plasma/Serum | 85 |
| 82108, 82570 | Aluminum, Urine (+ creatinine) | 1 |
| 83885 | Nickel, Plasma | 1 |
| 83785 | Manganese, Plasma | 4 |
| 83785, 82570 | Manganese, Urine | 1 |
| 84255 | Selenium, Urine | 1 |
| 82693 | Ethylene Glycol, Serum | 33 |
| 80338 | Trazodone, Serum | 3 |
| 80346 | Clonazepam (Klonopin),Serum | 75 |
| 80342 | Chlorpromazine, Serum | 1 |
| 80307 | Amphetamines Screen & Confirmation ( Confirm at additional charge), Urine | 1 |
| 80307 | Barbiturate Screen & Confirmation ( Confirm at additional charge) urine | 2 |
| 80307 | Benzodiazepine Screen & Confirmation ( Confirm at additional charge), Urine | 2 |
| 80307 | Cannabinoid (THC) Screen Urine & Confirmation (reflex confirm at additional charge) | 15 |
| 80307 | Cocaine Metabolite Screen & Confirmation ( Confirm at additional charge) Urine | 3 |
| 80307 | Methadone Screen & Confirmation ( Confirm at additional charge) Urine | 3 |
| 80307 | Opiate Screen (Codeine & Morphine) and Confirmation, Urine (Confirm at additional charge) | 5 |
| 80307 | Phencyclidine (PCP) Screen and Confirmation, Urine (Confirm at additional charge)Qual, Urine | 5 |
| 80307 | Propoxyphene, Urine Screen and Confirmation (Confirm at additional charge) | 75 |
| 80367 | Propoxyphene Confirmation, Urine | 1 |
| 81003 | Hemoglobin, Free, Qual, Urine | 1 |
| 83735 | Magnesium, RBC | 2 |
| 82585 | Cryofibrinogen, Qualitative | 5 |
| 85302 | Protein C Antigen | 20 |
| 85549 | Lysozyme, Serum | 64 |
| 84255 | Selenium, Blood | 11 |
| 82525 | Copper, WB | 3 |
| 82652 | Calcitriol(1,25 di-OH Vit D) | 4000 |
| 83516(X2) | Desmoglein 1 and 3 | 1 |
| 82638 | Dibucaine Number | 4 |
| 83520(x2) | Creutzfeldt-Jakob Disease | 4 |
| 86305 | Human Epididymis Protein 4 | 1 |
| 80299 | Pyrazinamide, GC/MS | 3 |
| 80299 | Ethambutol, GC/MS | 2 |
| 84402, 84403 | Testosterone, Free and Total Equilibrium | 175 |
| 82725 | Fatty Acids, Free (Nonester) | 1 |
| 82306 | Vitamin D, 25-Hydroxy | 10 |
| 84270 | Sex Horm Binding Glob, Serum | 800 |
| 86255 | Antiadrenal Antibodies, Quant | 13 |
| 86780 | T pallidum Screening Cascade (reflex positive antibodies) | 3 |
| 86780 | Treponema pallidum Antibodies | 112 |
| 86255 | Antiskin Autoantibodies, Quant | 21 |
| 83516 | Antiglomerular Basement Membrane Antibodies, Quant | 50 |
| 86641 | Cryptococcus Antibodies, Quant | 1 |
| 86382 | Rabies Neut.Abs Titrat.(RFFIT) | 10 |
| 87389 | HIV p24 Antigen/antibody screen (w/reflex to HIV 1-2 differentiation if positive) | 10 |
| 87536 | HIV RNA Qualitative | 5 |
| 86701, 86702 | HIV 1/2 differentiation (Panel 083955) w reflex to qualitative RNA by NAA testing if negative | 120 |
| 87535, 87538 | HIV-1/HIV-2 Qualitative RNA | 23 |
| 87535, 87538 | HIV-1/HIV-2 Qualitative RNA | 1 |
| 82384 | Catecholamines, Plasma | 110 |
| 85240, 85245, 85246 | von Willebrand Profile | 40 |
| 80367 | Propoxyphene,Serum | 1 |
| 83825 | Mercury, Blood | 30 |
| 82300 | Cadmium, Blood | 10 |
| 87278 | Legionella pneumophila DFA | 23 |
| 80299 | Flecainide (Tambocor), Serum | 6 |
| 83519 | AChR Binding Abs, Serum | 215 |
| 83519 | AChR Blocking Abs, Serum | 120 |
| 82042, 82784(2), 82040 | Immunoglobulin G,Syn Rate,CSF | 1 |
| 83519(2), 86255 | Acetylcholine Receptor (AChR) Ab, complete profile |
Gentry, Holly C (V16): Gentry, Holly C (V16):
AChR binding antibody, AChR-blocking antibody, AChR-modulating antibody
| 40 | ||
| 87324 | C difficile Toxins A+B, EIA | 4 |
| 85210 | Factor II Activity | 4 |
| 85220 | Factor V Activity | 11 |
| 85240 | Factor VIII Activity | 35 |
| 85246 | von Willebrand Factor (vWF) Ag | 3 |
| 85250 | Factor IX Activity | 10 |
| 85260 | Factor X Activity | 4 |
| 85270 | Factor XI Activity | 9 |
| 85280 | Factor XII Activity | 5 |
| 85291 | Factor XIII | 2 |
| 86329 | Teichoic Acid Antibodies | 1 |
| 87070 | Legionella Species Culture | 50 |
| 87109 | Mycoplasma pneumoniae Culture | 1 |
| 87109 | Ureaplasma/Mycoplasma hominis | 100 |
| 83540 | Iron, 24 Hour Urine | 1 |
| 87186 | Min Inhibitory Conc (2 Drugs) | 2 |
| 87186 | Min Inhibitory Conc (3 Drugs) | 1 |
| 87186 | Min Inhibitory Conc (4+ drugs) | 1 |
| 82150 | Amylase, Body Fluid | 117 |
| 82103, 82104 | Alpha-1-Antitrypsin Phenotyp | 175 |
| 86756 | RSV Ab, Quant | 1 |
| 86632 | Chlamydia trachomatis Ab, IgM | 30 |
| 86631 | Chlamydia Antibodies, IgG | 50 |
| 86787 | Varicella-Zoster V Ab, IgG | 1700 |
| 86665 | Epstein-Barr Ab to Viral Capsid Ag, IgG | 15 |
| 86663 | Epstein-Barr Early Antigen Ab, IgG | 10 |
| 86658(X6) | Coxsackie Virus Group B Ab | 10 |
| 86215 | Anti-DNase B Strep Antibodies | 5 |
| 86225 | Anti-dsDNA Antibodies | 1020 |
| 82135 | ALA Delta, 24-Hour Urine | 2 |
| 87186 | Min Inhibitory Conc (MIC) one drug | 5 |
| 86762 | Rubella Antibodies, IgM | 5 |
| 86735 | Mumps Antibodies, IgG | 650 |
| 86765 | Measles (Rubeola) Antibodies, IgG | 1200 |
| 86778 | Toxoplasma gondii Ab,IgM,Quant | 160 |
| 86628 | Candida Antibodies, Qual | 3 |
| 86645 | Cytomegalovirus (CMV) Ab, IgM | 450 |
| 86665 | Epstein-Barr Ab to Viral Capsid (VCA) Ag, IgM | 15 |
| 86787 | Varicella-Zoster Ab, IgM | 125 |
| 86355, 86359, 86360 | T + B-Lymphocyte Differential | 1 |
| 86359, 86360 | T-Lymphocyte Helper/Suppressor | 1 |
| 86332 | Immune Complexes, C1q Binding | 5 |
| 86160 | Complement C3, Body Fluid | 1 |
| 83615 | LD, Body Fluid | 225 |
| 86160 | Complement C4, Body Fluid | 1 |
| 82438 | Chloride, Body Fluid | 1 |
| 82570 | Creatinine, Body Fluid | 10 |
| 82985 | Fructosamine | 1100 |
| N/A non human | Glucose, Dialysate | 1 |
| 84478 | Triglycerides, Fluid | 55 |
| 84520 | Urea Nitrogen (Body Fluid) | 3 |
| 82951, 82952 | Gestational Glucose Tolerance | 1 |
| 83036 | Hgb A1c by IA with eAG Estimation | 7 |
| 88185 | CD1a - Flow - Tech | 5 |
| 88185 | CD41 - Flow - Tech | 15 |
| 88185 | CD59 - Flow - Tech | 3 |
| 88185 | CD52 - Flow - Tech | 5 |
| 88185 | CD62 - Flow - Tech | 14 |
| 88185 | CD71 - Flow - Tech | 15 |
| 88185 | CD158a - Flow -Tech | 2 |
| 88185 | CD138 - Flow - Tech | 47 |
| 88185 | CD326 Ep-CAM (Ber-EP4) - Flow | 8 |
| 88185 | TcR-gamma/delta - Flow Tech | 9 |
| 88185 | cCD22 - Flow - Tech | 9 |
| 88185 | cCD79a - Flow - Tech | 12 |
| 88323 | Surgical Pathology Consultation - 88323 | 14 |
| 85097 | Bone Marrow Aspirate Smear Interpretation | 50 |
| 85060 | Peripherial Bld Smear Interpretation | 30 |
| 88185 | CD3 - Flow - Tech | 13 |
| 88185 | CD11c - Flow - Tech | 1 |
| 88185 | CD13 - Flow - Tech | 2 |
| 88185 | CD33 - Flow - Tech | 2 |
| 88185 | CD103 - Flow - Tech | 1 |
| 88185 | CD25 - Flow - Tech | 20 |
| 88185 | CD34 - Flow - Tech | 5 |
| 88185 | CD117 - Flow - Tech | 2 |
| 88185 | CD16 - Flow - Tech | 3 |
| 88185 | cKappa - Flow - Tech | 65 |
| 86359, 86360 | CD4/CD8 Evaluation | 4 |
| 88185 | cLambda - Flow - Tech | 65 |
| 88185 | TdT - Flow - Tech | 14 |
| 88185 | CD30 -Flow - Tech | 4 |
| 81261 | Ig Hvy Chain Gene Rearrang. | 1 |
| 88184, 88185(X8), 88187 | PNH Panel Flow Cytometry | 6 |
| 88184, 88185(x23) | Comprehensive Panel | 1 |
| 88187 | Interp (2-8 Markers) | 12 |
| 81206, 81207 | BCR/ABL Quant PCR | 71 |
| 81270 | JAK2 Quantitative | 14 |
| 88185 | CD235a - Flow - Tech | 20 |
| 81270 | JAK2 Qualitative | 110 |
| 81263 | IgVH Somatic Hypermutation-TN | 7 |
| 81263 | IgVH Somatic Hypermutation-CA | 13 |
| 88271(x2), 88274 | ALK Lung-TN | 1 |
| 88271(x2), 88274 | ALK Lung-CA | 1 |
| 88185 | cMPO (Myeloperoxidase) - Flow | 13 |
| 88185 | CK (Cytokeratin) - Flow | 5 |
| 88184, 88185(x23), 88189 | Comprehensive Panel | 120 |
| 88184, 88185(x18), 88189 | Tissue Panel | 80 |
| 81263 | IgVH Somatic Hypermutation | 10 |
| 88271(x4), 88275(x4) | MDS (PhD) | 14 |
| 88237 | Culture Process (TECH) | 8 |
| 88381 | Microdissection - Global | 25 |
| 81235 | EGFR Mutation Analysis, NSCLC | 8 |
| 88185 | CD158b-Flow-Global | 2 |
| 88185 | CD158e-Flow-Global | 2 |
| 88185 | CD26-Flow-Global | 6 |
| 82271(x10), 88275(X7) | Plasma Cell Myeloma (Kreatech) | 20 |
| 82271(x6), 88275(X3) | Chronic Lymphocytic Leuk-CA | 16 |
| 82271(x10), 88275(X7) | Myeloma (Kreatech) Panel-CA | 3 |
| 82271(x7), 88275(X3) | MPN w/Eosinophilia-TN | 1 |
| 82271(x6), 88275(X5) | MPN/CML-TN | 3 |
| 82271(x10), 88275(X7) | Myeloma (Kreatech) Panel-TN | 1 |
| 82271(x10), 88275(X7) | Plasma Cell Myeloma (Kreatech) | 30 |
| 82271(x6), 88275(X3) | Chronic Lymphocytic Leuk-TN | 13 |
| 82271(x4), 88275(X4) | MDS (PhD) | 15 |
| 82271(x10), 88275(X6) | AML Panel | 2 |
| 82271(x10), 88275(X6) | AML Panel | 9 |
| 81340, 81342 | T-Cell (TRB & TRG) Gene Rearr | 9 |
| 81261, 81264 | B-Cell(IGH&IGK) Gene Rearrange | 4 |
| 81261, 81264, 81340, 81342 | B/T Cell Rearr:IGH,IGK,TRG,TRB | 5 |
| 81275, 81276 | KRAS Mutation by Snapshot | 5 |
| 81219 | CALR Mutation Analysis | 21 |
| 81210 | BRAF Mutation by Snapshot | 15 |
| 81311 | NRAS Mutation by PCR Snapshot | 5 |
| 81305 | MYD88 Mutation Detection PCR | 9 |
| 88237, 88264 | Cancer Cytogenetics Bone Marro | 151 |
| 88261, 88280, 88237 | 5 cells 1 karyotype BM/PB | 1 |
| 88237, 88264 | Cancer Cytogentics-Peripheral | 10 |
| 88237, 88264 | Cancer Cytogenetics-Lymph Node | 2 |
| 88261, 88237, 88285, 88280 | 6-14 cells karyotype BM/PB | 5 |
| 88261, 88239, 88285, 88280 | 6-14 cells karyotype LN/Tumor | 1 |
| 85379 | D-Dimer | 88 |
| 88237, 88262, 88280 | 15-20 cells karyotypes BM/PB | 1 |
| 85049 | Platelet Count on Citrated Bld | 1 |
| 85362 | Fibrinogen Degradation Products, (FDP) Plasma | 1 |
| 81301 | Microsatelite Instab.-Promega | 10 |
| 88264 | Slides-Cancer Cytogenetics | 4 |
| 88237 | PHX-Tissue Cult for Chromo.Ana | 3 |
| 88360 | PD-L1 IHC Keytruda (TC)-OmniSeq | 4 |
| 88377 | MDM2 by FISH | 3 |
| 88185 | Flow - BC1 - Tech | 2 |
| 88271(x6) | FISH DNA Probe x6 | 1 |
| 88275(x3) | FISH analyze 100-300 cells x3 | 1 |
| 83520 | Vascular Endothelial Growth Factor (VEGF), Plasma | 1 |
| 85598 | Hexagonal Phase Phospholipid | 16 |
| 83520 | Vascular Endothelial Growth Factor (VEGF), Serum | 2 |
| 85610, 85611 | PT Mixing Study | 2 |
| 85732 | PTT-LA Incub Mix | 6 |
| 85732 | PTT-LA Mix | 23 |
| 80375 | Rivaroxaban | 4 |
| 85385 | Fibrinogen Antigen | 1 |
| 85613, 85670, 85705, 85732 | Lupus Anticoagulant Comprehensive | 65 |
| 85598, 85610, 85613, 85670, 86146(2), 86147(2) | Antiphospholipid Syndrome Profile | 1 |
| 85520 | Heparin Anti-Xa | 2 |
| 85670 | Thrombin Time Mix+Thrombin Time Neutralization | 2 |
| 86022 (x7) | Plt Antibody Profile Comprehensive |
Gentry, Holly C (V16): Gentry, Holly C (V16):
HLA Class 1 Ab, II/IIIa Ab, Ib/IX Ab, Ia/IIa Ab, Plt Assoc Anti-IIb/IIIa, Plt Assoc Anti-Ib/IX
| Plt Assoc Anti-Ia/IIa | 43 | ||
| 85240, 85730, 85732(X3) | Factor VIII Inhibitor Assay Comprehensive | 2 | |
| 85635 | Reptilase Time | 1 | |
| 85730, 85732(3) | aPTT Mixing Studies | 4 | |
| 85303 | Protein C-Functional | 95 | |
| 85420 | Plasminogen Activity | 1 | |
| 85410 | Alpha-2-Antiplasmin | 3 | |
| 85305, 85306(2) | Protein S Deficiency Panel | 55 | |
| 85307 | Activated Protein C Resistance | 16 | |
| 85598 | Hexagonal Phase Phospholipid (neutralization) | 20 | |
| 85732, 85613 | Lupus Anticoagulant Reflex | 85 | |
| 85260 | Factor X, Chromogenic | 1 | |
| 85613 | dRVVT (Dilute Russell Viper Venom) Mix | 48 | |
| 85397 | ADAMTS13 Activity | 10 | |
| 83520 | ADAMTS13 Antibody (direct order) | 2 | |
| 83520 | ADAMTS13 Antibody (reflexed from 117921) | 2 | |
| 85397 | ADAMTS13 Activity Reflex Panel | 5 | |
| 85597 | dRVVT Confirm | 50 | |
| 83520 | ADAMTS13 Antibody | 1 | |
| 86148(3) | Antiphosphatidylserine IgG/M/A | 7 | |
| 88377 | HER2 Breast (MD) | 6 | |
| 88377 | HER2 Gastric (MD) | 10 | |
| 84999 | Osmolality, Fecal | 8 | |
| 83695 | Lipoprotein (a) | 345 | |
| 84260 | Serotonin, Serum | 163 | |
| 86161 | C1 Esterase Inhibitor, Functional | 59 | |
| 82491 | Coenzyme Q10, Total | 1 | |
| 83150 | Homovanillic Acid, 24-Hr Urine | 1 | |
| 82784 (x3) 83521 (X2) 84155, 84165, 86334 | IFE, PE and Free Light Chains, (Quant Free Kappa and Lambda Light Chains Plus Ratio), Serum | 1 | |
| 82530 | Cortisone, Urine | 7 | |
| 86335 | Immunofixation (IFE) Reflex, Random Urine | 2 | |
| 86335 | Immunofixation (IFE) Reflex, 24-hr Urine | 10 | |
| 86141 | C-Reactive Protein, HS (Cardiac Risk) | 2 | |
| 82553 | Creatine Kinase (CK), MB | 1 | |
| 84484 | Troponin I | 1 | |
| 83021 | Hgb Fetal, Quant | 1 | |
| 84155, 84165, 83521(x2), | Cryoglobulin, Ql, Serum | 7 | |
| 84120 | Porphyrins, Qn, Random U | 11 | |
| 84120 | Porphyrins, Quant, Random Utine | 4 | |
| 83021 | Hgb A2, Quant | 3 | |
| 83883(2) | Free Kappa + Lambda Lt Chains, Quant, Serum | 1830 | |
| 84425 | Vitamin B1 (Thiamine), Blood | 1600 | |
| 84597 | Vitamin K1 | 110 | |
| 83883(2) | Free K+L Lt Chains,Quant,Urine | 175 | |
| 82610 | Cystatin C | 75 | |
| 83883 (x2) | Free K+L Lt Chains,Quant,24 hr Urine | 3 | |
| 82610 | Cystatin C with Glomerular Filtration Rate, Estimated (eGFR) | 100 | |
| 83020 | Hemoglobinopathy Fractionation Cascade Capillary Electrophoresis (CE) reflex to HPLC and/or Hgb solubility | 800 | |
| 85660 | Hgb Solubility (reflexed from 121690) | 65 | |
| 83020 | Hgb Fractionation by HPLC | 39 | |
| 83020, 85660 | Hgb Frac by HPLC+Solubility (reflexed from 121690) | 11 | |
| 83835 | Metanephrines, Frac., Plasma Free | 550 | |
| 83883 | Alpha-2-Macroglobulins, Quant | 1 | |
| 84156, 84166, 86335 | Iummofixation Electrophoresis and Protein Electrophoresis, Random Urine | 65 | |
| 83605 | Lactic Acid, CSF | 1 | |
| 82103 | Alpha-1-Antitrypsin, Stool | 2 | |
| 86332 | C3d Immune Complexes | 1 | |
| 83631 | Lactoferrin, Fecal, Quant. | 1 | |
| 84166, 84156 | Protein Electrophoresis + Interp 24 hr urine (with Reflex to IFE) | 170 | |
| 84165, 84155 | Protein Electrophoresis + Interp Serum (with Reflex to IFE) | 1010 | |
| 86335 | Immunofixation (IFE), Urine | 5 | |
| 82784, 82787(x2) | IgA, Subclasses (1-2) | 1 | |
| 83883 | Retinol binding Protein(RbP) | 1 | |
| 82040, 82042, 82748(X2), 83916 | Multiple Sclerosis(MS) Profile | 8 | |
| 82150(2) | Amylase Isoenzymes | 50 | |
| 82373 | Carbohydrate Deficient Transferrin (CDT) | 45 | |
| 84252 | Vitamin B2, Whole Blood | 19 | |
| 82164 | Angiotensin Converting Enzyme (ACE), CSF | 23 | |
| 82656 | Pancreatic Elastase, Fecal | 645 | |
| 83993 | Calprotectin, Fecal | 1100 | |
| 81332, 82103 | Alpha-1-Antitrypsin Deficiency, Quant & DNA analysis (Reflexes to Phenotype ) | 10 | |
| 84392 | Sulfate, Quant, 24-Hour Urine | 60 | |
| 83873 | Myelin Basic Protein, CSF | 1 | |
| 82040, 82042, 82784(2), 83873, 83916 | MS Profile+MBP, CSF | 8 | |
| 88121 | Bladder Cancer, FISH, Pathologist Review/Urovysion MD read (bill H00062) | 1 | |
| 86612(x2) | Blastomyces dermatitidis Ab ID | 1 | |
| 86632 | Chlamydia psittaci IgM Ab | 2 | |
| 86631 | Chlamydia psittaci IgG Ab | 4 | |
| 87484 | Ehrlichia chaffeensis PCR | 106 | |
| 86631 | Chlamydia pneumoniae IgG Ab | 1 | |
| 87799 | Epstein-Barr DNA Quant, PCR | 31 | |
| 86684 | Haemophilus influenzae B IgG | 2 | |
| 87798 | Epstein-Barr Virus PCR (Qualitative) | 72 | |
| 87798 | Varicella Zoster Virus VZV Real time DNA PCR | 33 | |
| 86753(2) | Babesia microti Antibody Panel | 7 | |
| 87798 | Babesia microti, PCR | 3 | |
| 86631, 86632 | Chlamydia pneumoniae(IgG/M) | 2 | |
| 86682 | Cysticercosis (Taenia solium) | 7 | |
| 87471 | Bartonella DNA PCR | 24 | |
| 87252, 87253 | HSV Acyclovir Resistance | 1 | |
| 86631 | Chlamydia trachomatis IgG Ab | 1 | |
| 8746887484 | Ehrlichia Detection PCR | 2 | |
| 87581 | Mycoplasma pneumoniae, DNA PCR | 1 | |
| 86635 | Paracoccidiodes Brasiliensis Ab Total, IgG and IgM, Immunodiffusion | 1 | |
| 87532 | Human Herpes Virus 6 PCR | 1 | |
| 86790 | HHV-6, (Human Herpes Virus) IgM, IF | 5 | |
| 86658(3) | Poliovirus 1,2,3 Antibody (Immune Status) | 1 | |
| 86784 | Trichinella spiralis Antibody | 1 | |
| 87798 | Toxoplasma gondii PCR | 1 | |
| 87498 | Enterovirus RT-PCR | 8 | |
| 87798 | Parvovirus B19 PCR | 15 | |
| 87529(2) | HSV 1/2 DNA PCR Swab, WB, serum or plasma | 550 | |
| 87798(2) | B.pertussisB.parapertussis PCR | 6 | |
| 87476 | Lyme RT PCR, Borrelia burgdorferi | 15 | |
| 87496 | CMV PCR | 25 | |
| 86757 (x2) | Typhus Fever Group IgG and IgM | 20 | |
| 86682 | Echinococcus Antibody | 5 | |
| 86788, 86789 | West Nile Virus Antibody,Serum | 50 | |
| 87799 | BKV Quant PCR (Urine) | 60 | |
| 86790 | Donor, HTLV-I/II Ab | 1 | |
| 87799 | BK Virus Quant PCR (Plasma/Serum) | 430 | |
| 86788, 86789 | West Nile Virus Antibody, CSF | 25 | |
| 86632 | Chlamydia pneumoniae IgM | 1 | |
| 87497 | CMV Quant DNA PCR (Urine) | 1 | |
| 87497 | CMV Quant DNA PCR (Plasma) | 650 | |
| 86635 | Coccidioides ID Antibody | 1 | |
| 86635 | Coccidioides CF Antibody | 2 | |
| 87633 | Respiratory Virus Panel (RVP) PCR | 1 | |
| 86753 | Donor, T. cruzi (Chagas) | 1 | |
| 87533 | Human Herpesvirus 6 (HHV-6) Quant DNA PCR | 1 | |
| 87799 | Parvovirus B19, Quant PCR | 6 | |
| 87798 | JC Virus DNA, PCR (CSF) | 8 | |
| 87529(2), 87798 | HSV and VZV PCR Panel | 7 | |
| 87798 | JC Virus DNA,PCR (Whole Blood) | 50 | |
| 87798 | JC Virus DNA, PCR (Urine) | 1 | |
| 87798 | Plasmodium Species. PCR | 2 | |
| 86710 (3) | Respiratory Profile, PCR | 1 | |
| 87529(2) | HSV 1/2 DNA PCR, CSF | 75 | |
| 87535, 87538 | HIV-1/HIV-2 Qualitative RNA | 17 | |
| 87798 | Varicella Zoster Virus (VZV) PCR, CSF | 35 | |
| U0003 (AMA:87635) | SARS CoV-2 EUA Molecular Testing, NAA | 10 | |
| U0003, (AMA:87635) | COVID-19 NAA, Saliva | 5 | |
| 82107, 83951 | Hepatocellular Carcinoma Risk | 1 | |
| 87798 | West Nile Virus, NGI UltraQual RT PCR | 10 | |
| 87798 | West Nile Virus, NGI SuperQual RT PCR | 1 | |
| 82043 | Albumin, 24 hr Urine | 20 | |
| 83520 | anti-Myelin Associated Glycoprotein (MAG) IgM Autoantibodies | 55 | |
| 84484 | Troponin T, high sensitivity | 30 | |
| 83520 | Insulin-like Growth Factor Pinding Protein 3 (IGFBP-3) | 10 | |
| 87502 | Influenza (Flu) A+B NAA | 1 | |
| 82670 | Estradiol, Sensitive | 679 | |
| 83520 | Alpha Subunit (Free) | 50 | |
| 82668 | Erythropoietin (EPO), Serum | 385 | |
| 83520 | GM1 IgM Autoantibodies | 5 | |
| 82043, 82570 | Albumin/Creat Ratio, Random Urine | 3 | |
| 86300 | CA 27.29 | 35 | |
| 83520 | GM1 IgG Autoantibodies | 5 | |
| 84702 | HCG Tumor Marker | 150 | |
| 84206 | Proinsulin | 60 | |
| 86316 | Neuron-specific Enolase, Serum | 2 | |
| 87522 | HCV Quant. PCR NGI QuantaSURE (2IU/ml - 2,000,000 IU/ml) | 1 | |
| 83516 | VGCC (Voltage-gated Calcium Channel) Antibody | 12 | |
| 83520 | Human Anti-mouse Antibodies | 10 | |
| 86803 | HCV Antibody | 1 | |
| 83520 | Tumor Necrosis Factor-Alpha | 52 | |
| 84152 | PSA, Complexed (cPSA) | 1 | |
| 84140 | Pregnenolone, Mass Spec | 1 | |
| 84143 | 17-Hydroxypregnenolone, MS | 10 | |
| 84153 | PSA, Ultrasensitive W/O Serial | 20 | |
| 84445 | Thyroid Stimulating Immunoglobulin | 925 | |
| 86316 | Chromogranin A | 425 | |
| 82523 | Intact N-Terminal Propeptide Type I ProCollagen | 30 | |
| 83880 | B-Type Natriuretic Peptide Plasma | 1 | |
| 83520 | Interleukin-2, Serum | 3 | |
| 83520 | Interleukin-6 (IL-6) | 250 | |
| 83520 | Interleukin-8, Serum | 1 | |
| 82523, 82570 | N-Telopeptide, Urine | 15 | |
| 82107 | AFP with AFP-L3% | 1 | |
| 83951 | Des gamma carboxy Prothrombin | 1 | |
| 83516 | Phospholipase A2 Receptor Autoantibodies, IgG (Anti-PLA2R) | 180 | |
| 82607 | Vitamin B12 Deficiency Cascade | 1 | |
| 86341 | IA-2 Autoantibodies | 30 | |
| 86337 | Insulin Antibodies | 150 | |
| 83519 | Insulin-like Growth Factor 2 (IGF-2) | 12 | |
| 82378 | CEA, Fluid | 20 | |
| 83520 | Interleukin-2 (IL-2) Receptor Alpha | 8 | |
| 83880 | NT- proBNP (B-Type Natriuretic Peptide) serum | 100 | |
| 86341 | GAD-65 (Glutamic Acid Decarboxylase) Autoantibody | 600 | |
| 84403, 84402 | Testosterone, Free+Weakly Bound | 1000 | |
| 84238 | Soluble Transferrin Receptor | 35 | |
| 86300 | Cancer Antigen (CA) 15-3 | 30 | |
| 86803 | HCV Antibody RFX to Quant PCR | 1 | |
| 83088 | Histamine, Plasma | 11 | |
| 83088 | Histamine Determination, Urine | 2 | |
| 84402 | Testosterone, Free, Direct Measure | 1975 | |
| 83519 | Pancreatic Polypeptide | 9 | |
| 85415 | Plasminogen Act Inhibitor-1 | 1 | |
| 83520 | Inhibin B | 2 | |
| 86335 | Inhibin A, Ultrasensitive | 1 | |
| 82542 (x2) | Serotonin Release Assay (SRA) Heparin-dependent Platelet Antibody | 15 | |
| 86022 | Heparin Induced Platelet W/Reflex to SRA | 1 | |
| 86022 | Heparin Induced Platelet | 15 | |
| 88237; 88264; 88271(x2); 88273; 88275; 88280 (x2) | CML Chromosome Analysis BCR-ABL /FISH Profile |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| BCR-ABL for chronic myelogenous leukemia (CML), FISH; chromosome analysis; quantitative monitoring for CML by FISH; ABL deletions are confirmed by linked ASS analysis. | 1 | ||
| 86255 | Striational Antibodies | 25 | |
| 82480 | Cholinesterase, Plasma | 1 | |
| 86765 | Measles (Rubeola) Antibodies, IgM | 2 | |
| 86617(2) | Lyme, Western Blot, CSF | 5 | |
| 86735 | Mumps Antibodies, IgM | 10 | |
| 82787 | IgG, Subclass 1 | 2 | |
| 82787 | IgG, Subclass 2 | 1 | |
| 82787 | IgG, Subclass 3 | 1 | |
| 82787 | IgG, Subclass 4 | 149 | |
| 86341 | Antipancreatic Islet Cells | 200 | |
| 86790 | HHV-6, IgG Antibodies, Quant | 5 | |
| 86160 | Complement C2 | 10 | |
| 86235 | Anti-Jo-1 | 200 | |
| 86258 | Deaminated Gliadin Antibodies (Antigliadin Abs), IgA | 1 | |
| 83516 | Deaminated Gliadin Antibodies (Antigliadin Abs) IgG (native) | 2 | |
| 86615 | B pertussis IgG Ab | 2 | |
| 86615 | B pertussis IgM Ab | 2 | |
| 86255 | Reticulin IgA Antibodies | 2 | |
| 86147(2) | Anticardiolipin Ab (ACA), IgG/M, Quant | 587 | |
| 86147 | Anticardiolipin Ab (ACA), IgG, Quant | 1 | |
| 86147 | Anticardiolipin Ab, (ACA), IgM, Quant | 1 | |
| 86147 | Anticardiolipin Ab (ACA), IgA, Quant | 1 | |
| 86147(3) | Anticardiolip Ab (ACA), IgA/G/M, Quant | 100 | |
| 83516(x3) 86036,86671 | Inflammatory Bowl Disease (IBD) Expanded Panel | 40 | |
| 86677 | H.pylori, IgG Abs | 40 | |
| 86037 (x3) | Antineutrophil Cytoplasmic Ab | 200 | |
| 86146(2) | Beta-2 Glycoprotein I Ab,G/M | 310 | |
| 86628 | Candida Antibodies IgG, ELISA | 1 | |
| 86615(2) | B pertussis IgG/IgM Ab | 1 | |
| 83516 | Glomerular basement membrane (Anti-GBM) Antibodies serum | 120 | |
| 83516 | Antimyeloperoxidase (MPO) Antibodies serum | 95 | |
| 83516(2), 86037(3) | Antineutrophil Cytoplasmic Antibody (ANCA) Profile | 420 | |
| 83520 | Anti-PR3 Antibodies | 78 | |
| 86794 | Zika Virus Antibody, IgM | 2 | |
| 86747 | Parvovirus B19, IgM | 1 | |
| 86611(4) | Bartonella Antibody Panel | 76 | |
| 86677 | Helicobacter pylori, IgM Ab | 280 | |
| 86738 | Mycoplasma pneumoniae, IgM Ab | 5 | |
| 86790 | HTLV-I/II Antibodies, Qual | 15 | |
| 86317(2) | Tetanus/Diphtheria Ab | 10 | |
| 86658(4) | Coxsackie A Antibody Profile, IgG | 4 | |
| 86658(X5) | Coxsackie A Antibody Profile, IgG/IgM | 9 | |
| 86747(2) | Parvovirus B19, Human, IgG/IgM | 35 | |
| 83516(2) | Gliadin IgG/IgA Ab Prof, EIA | 700 | |
| 86617(2) | Lyme, Line Blot, Serum | 1 | |
| 86677(X3) | H pylori, IgM, IgG, IgA Ab | 3 | |
| 86317 | Tetanus Antitoxoid IgG Ab | 28 | |
| 86317 | Diphtheria Antitoxoid Ab | 11 | |
| 86738 | Mycoplasma pneumoniae, IgG Ab | 7 | |
| 86738(2) | Mycoplasma pneumoniae IgG/IgM Abs | 49 | |
| 86146 | Beta-2 Glycoprotein I Ab, IgA | 1 | |
| 86146 | Beta-2 Glycoprotein I Ab,IgM | 1 | |
| 86146 (3) | Beta-2 Glycoprotein I Ab,G/A/M | 75 | |
| 86376 | Liver-Kidney Microsomal Ab | 150 | |
| 86682 | Strongyloides Ab IgG, ELISA | 73 | |
| 82784,83516 (x2) | Celiac Ab tTG DGP TIgA | 1 | |
| 86769 | SARS CoV-2 Ab IgG | 10 | |
| 86200, 86431 | Rheumatoid Arthritis Profile | 1 | |
| 86769 | SARS CoV-2 Antibodies, Nucleocapsid Ab | 25 | |
| 86769 | SARS CoV-2 Ab IgA | 1 | |
| 86618(x2) | Lyme IgG/IgM | 20 | |
| 86769 | SARS-CoV-2 Semi-Quant Total Ab, Spike Ab | 1 | |
| 86696 | HSV-2 Ab, IgG | 170 | |
| 86695, 86696 | HSV 1 and 2 Ab, IgG | 1,500 | |
| 86687, 86688 | HTLV-I/II Differentiation (Immunoblot) | 15 | |
| 86618 | Lyme Disease Serology w/Reflex to IgG & IgM | 340 | |
| 86790 | HTLV-I/II Antibodies, Qual. (with confirmation) | 5 | |
| 86606(3) | Aspergillus Ab, Quant , DID | 45 | |
| 86612 | Blastomyces Abs, Quant , DID | 20 | |
| 86635 | Coccidioides Abs, Quant , DID | 1 | |
| 86698(2) | Histoplasma capsulatum Abs. complement fixation | 80 | |
| 86615 | B pertussis IgA Ab | 2 | |
| 85245 | von Willebrand (VW) Factor Activity | 13 | |
| 85305, 85306 | Protein S-Antigen | 1 | |
| 85306 | Protein S-Functional | 102 | |
| 86615(3) | B pertussis IgG/M/A Ab | 3 | |
| 86622 | Brucella Antibody IgG, EIA | 20 | |
| 86713 | Legionella pneumophila Abs. | 4 | |
| 86622 | Brucella Antibody IgM, EIA | 13 | |
| 86622(2); 86757(4) | Febrile Antibody Profile |
Gentry, Holly C (V16): Gentry, Holly C (V16):
IgG and IgM antibodies to Brucella spp, Rickettsia rickettsiae gp (Rocky Mountain spotted fever), and Rickettsia typhi gp (typhus fever).
| 4 | ||
| 86622(2) | Brucella Antibody IgG/IgM | 10 |
| 83516 | t-Transglutaminase (tTG) IgA | 1250 |
| 86671(2) | Saccharomyces cerevisiae Panel | 275 |
| 86666(4) | Ehrlichia Ab Panel | 1 |
| 86666(2) | Ehrlichia chaffeensis Ab | 170 |
| 86666(4) | Ehrlichia Ab Panel (granulocytic and monocytic) |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| Ehrlichia Antibody Panel, Anaplasma phagocytophilum and Ehrlichia chaffeensis, IgG and IgM, IFA | 4 | ||
| 84145 | Procalcitonin | 45 | |
| 86666 | Human Gran. Ehrlichiosis (IgG) | 10 | |
| 86635(2) | Coccidioides immitis Abs, IgG/IgM, EIA | 24 | |
| 86235 | Anti-Centromere B Antibodies | 115 | |
| 86037, 86671(2) | Inflammatory Bowel Disease-IBD Profile | 10 | |
| 86038 | Antinuclear Antibodies Direct (multiplex assay) | 1 | |
| 86695 | HSV I Antibody, IgG | 1 | |
| 86200 | CCP Antibodies IgG/IgA | 3495 | |
| 83516, 86225, 86235(x9) | Antinuclear Ab 11 by Multiplex | 2 | |
| 86038 | Antinuclear Antibodies, by IFA Reflex Titer/Pattern | 1150 | |
| 83516 | t-Transglutaminase (tTG) IgG | 500 | |
| 86255 | Endomysial Antibody IgA | 65 | |
| 86225; 86235(x8) | ANA Comprehensive Panel |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| Antinuclear Ab Profile, 9-biomarker Profile, by Multiplex Immunoassay, dsDNA, RNP, Sm, SS-A, SS-B, Scl-70, Chromatin, Jo-1, Centromere B | 1 | ||
| 82784, 83516(4), 86255 | Celiac Disease Comprehensive Antibody Panel (Deaminated gliadin antibodies; endomysial antibodies; tissue transglutaminase (tTG) antibodies; total IgA) | 575 | |
| 82784,83516(x2), 86255 | Celiac Disease II Immunoglobulin A; endomysial antibody IgA; tissue transglutaminase (tTG), IgA; tissue transglutaminase (tTG), IgG | ||
| 1 | |||
| 86255, 83516, 82784 | Celiac Disease Panel (with Reflex tTG) (Endomysial antibody, IgA; tissue transglutaminase (tTG), IgA; total IgA; reflex to tissue trransglutaminase (tTG), IgA) | 105 | |
| 83519 | Acetylcholine Receptor (AChR) Binding Abs with reflex to MuSK antibodies | 3 | |
| 83519(2), 86255 | Acetylcholine Receptor (AChR) Antibodies Complete profile with reflex to MuSK | 3 | |
| 83519(2), 86255(2) | Myasthenia Gravis Profile reflex to MuSK Abs |
Gentry, Holly C (V16): Gentry, Holly C (V16):
| AChR-binding antibodies, AChR-blocking antibodies, AChR-modulating antibodies, striational antibodies | 5 | ||
| 82172 | Apolipoprotein B | 55 | |
| 81377, 81383 | Celiac Disease HLA DQ Association | 22 | |
| 81377 | HLA DR15 | 2 | |
| 81381 | HLA-A*02:01 | 2 | |
| 81372 | HLA A,B,C (Intermediate Resolution- IR) | 1 | |
| 81375 | HLA DRB1,3,4,5,DQB1 (IR) | 1 | |
| 81381 | HLA-B*15:02 Carbamazepine Sensitivity | 6 | |
| 81379 | HLA A,B,C (CWD Resolution) | 1 | |
| 81383 (x2) | Narcolepsy Evaluation | 1 | |
| 81376 | HLA DRB1 (IR) | 2 | |
| 81373 | HLA-A (IR) | 2 | |
| 81373 | HLA-B (IR) | 2 | |
| 81380 | HLA-A (CWD Resolution) | 1 | |
| 81381 | HLA B*58:01 | 4 | |
| 81373 | HLA B*51 Disease Association | 2 | |
| 81381 | HLA-A29 Uveitis Birdshot Chorioretinopathy | 2 | |
| 82542 | Apolipoprotein (Apo) L1 Risk Variants | 2 | |
| 86828 | HLA Class 1,2 Antibody Screen | 5 | |
| 86830 | HLA Class I Antibody ID | 2 | |
| 86831 | HLA Class II Antibody ID | 2 | |
| 81379 | HLA A,B,C Profile (High Resolution) | 10 | |
| 86352 | Immuknow® | 2 | |
| 87491, 87591, 87661, 87798(3), 87801 | NuSwab Vaginitis Plus (VG+) | 1 | |
| 87563 | M genitalium NAA, Urine | 16 | |
| 87480, 87510, 87660 | Vaginitis/Vaginosis, DNA Probe | 175 | |
| 87563, 87798 (x2) | Genital Mycoplasma Profile NAA, Urine | 1 | |
| 87798 (x3), 87801 | NuSwab B Vaginosis and Candida, NAA | 1 | |
| 87798 | M genitalium NAA, Swab | 4 | |
| 87563, 87798(2) | Genital Mycoplasma Profile NAA, Swab | 3 | |
| 87046 | Campylobacter Culture | 2 | |
| 87281 | Pneumocystis Smear, DFA | 65 | |
| 87186 | Susceptibility, Anaerobic | 1 | |
| 87230 | C difficile, Cytotoxin B | 1 | |
| 87338 | H. pylori Stool Ag, EIA | 698 | |
| 87070 | Tissue Culture | 37 | |
| 87070 | Body Fluid Culture, Sterile | 15 | |
| 87070 | Aerobic Cult, Extended Incub | 1 | |
| 87802, 87899(3) | Bacterial Antigens (urine/CSF) | 1 | |
| 87070 | Lower Respiratory Culture | 10 | |
| 83013 | H. pylori Urea Breath Test | 185 | |
| 87177 | O+P Exam, PVA Only | 1 | |
| 87177 | O+P Exam, Formalin Only | 1 | |
| 87081, 87205 | Helicobacter pylori Culture (gastric) | 1 | |
| 87427 | E coli Shiga Toxin EIA | 2 | |
| 87186(4) | Antifungal Suscep 4 Drugs (Amphotericin B, Ketaconzole, Voriconzole and Caspofungin) | 1 | |
| 87186 | Antifungal Suscep AmphoB + Voriconazole | 1 | |
| 82271 | Occult Blood, Gastric Fluid | 3 | |
| 87329 | Giardia lamblia Ag, EIA | 425 | |
| 87106 | Organism Identification, Yeast | 10 | |
| 87186 | Antifungal Suscep, Fluconazole | 35 | |
| 87449 | L. pneumophila Serogp 1 Urine Ag | 20 | |
| 87077 | Aerobe ID + Susceptibility | 15 | |
| 87046 | Stool Culture, Vibrio Only | 3 | |
| 87186 | Antifungal Suscep,Amphotericin | 5 | |
| 87076 | Anaerobe Identification Only | 1 | |
| 87205 | Gram Stain w/Sputum Cult Rflx | 20 | |
| 87070 | Sputum Culture | 20 | |
| 87081 | Vancomycin-Resist Enterococcus, culture only | 1 | |
| 87206, 87015 | Cryptosporidium/Isospora Smear | 20 | |
| 87186 | Antifungal Suscep,Itraconazole | 1 | |
| 87188 (x5) | MTB Susceptibility Broth Dilution & Confirmation | 3 | |
| 87190(x6) | Mtb AST Confirmation | 1 | |
| 87101 | Yeast Only, Culture | 1 | |
| 87186 | Susceptibility, Gram Pos Rods | 1 | |
| 87186 | Mycobacterium avium Complex (MAC) Susceptibility Broth | 40 | |
| 87186 | Mycobacterium avium Complex (MAC) Susceptibility Broth | 23 | |
| 87186 | Nocardia Susceptibility Broth | 7 | |
| 87153 | Org ID by Sequencing Rflx AST | 25 | |
| 86480 | QuantiFERON (QFT) TB In Tube Gold Plus (4 tube, non-client incubated) | 550 | |
| 86480 | Quantiferon (QFT) TB Plus (4 tube, Client Incubated ) | 1150 | |
| 86480 | QuantiFERON (QFT) Gold-Plus (single tube collection) | 3825 | |
| 87186 | Mycobacterium Rapid Growing Broth Susceptibility | 9 | |
| 87186 | Rapid grower Broth Suscept | 5 | |
| 87176 | Slow Grower Broth Suscep. | 4 | |
| 87186 | Mycobacterium (non-TB) Slow Growing Broth Susceptibility | 1 | |
| 87176 | Slow Grower Broth Suscep. | 9 | |
| 87184 | Susceptibility, Haemophilus, IA | 1 | |
| 82274 | Occult Blood, Fecal, IA | 1 | |
| 87899 | Streptococcus pneumoniae Antigen (urine and csf) | 70 | |
| 87899 | Cryptococcus Antigen, CSF reflex to culture | 4 | |
| 87328 | Cryptosporidium Direct Detection EIA | 100 | |
| 87899 | Cryptococcus Antigen, Serum | 34 | |
| 86406 | Cryptococcus Ag Titer, Serum | 2 | |
| 87070, 87075, 87205 | Anaerobic/Aerobic/Gram Stain | 2 | |
| 87186 | Antifungal AST 9 Drug Panel | 3 | |
| 87015, 87206 | Cyclopora Smear, Stool | 65 | |
| 87176 | Tissue Grinding | 1 | |
| 87015 | Concentration | 800 | |
| 87176 | Tissue Grind/Digestion/Decon | 35 | |
| 87491, 87591, 87798 | CT, NG, Trich vag by NAA | 260 | |
| 87070; 87075 | Antifungal Suscep 4 Drugs | 1 | |
| 87491, 87591 | Chlamydia/GC Nucleic Acid Amplification (NAA) | 3500 | |
| 87186 | Antifungal Suscep 8 Drugs Microbroth Dilution (MIC) | 2 | |
| 87153 | Aerobic Bacteria, ID by Seq. | 15 | |
| 87153 | Organism ID | 2 | |
| 87153 | Nocardia, ID by Sequencing | 6 | |
| 87153 | Mycobacteria, ID by Sequencing | 5 | |
| 87153 | Yeast, ID by Sequencing | 1 | |
| 87153 | Mold, ID by Sequencing | 1 | |
| 87153 | Organism ID by Matrix- Assisted Laser Desorption/Ionization (MALDI) Time of Flight (TOF) Mass Spec (MS) Reflex AST | 5 | |
| 87153 | Organism ID by MALDI-TOF | 17 | |
| 87153 | Aerobic ID by MALDI-TOF | 15 | |
| 87153 | Anaerobic ID by MALDI-TOF | 1 | |
| 87153 | Nocardia ID by MALDI-TOF | 5 | |
| 87153 | Mycobacteria ID by MALDI-TOF | 7 | |
| 87081 | MRSA Screening Culture | 27 | |
| 87116, 87556, 87798 | MTB-RIF NAA with AFB Culture | 3 | |
| 87070, 87075, 87205 | Body Fluid Culture Aer/Ana/Gram Stain | 10 | |
| 87070, 87075 | Body Fluid Culture Aer/Anaer | 4 | |
| 87070, 87075 | Tissue Culture Aerobe/Anaerobe | 7 | |
| 87507 | GI Profile, Stool, PCR | 123 | |
| 87186 | Antifungal Susc, Anidulafungin | 1 | |
| 87186 | Antifungal Suscep, Caspofungin | 2 | |
| 87186 | Antifungal Suscep, Micafungin | 30 | |
| 87116, 87556, 87798 | MTB-RIF NAA with Culture, Non-Sputum | 25 | |
| 87385 | Histoplasma Gal'mannan Ag Ser | 50 | |
| 87186 | Antifungal Suscep,Posaconazole | 2 | |
| 87186 | Antifungal Suscep,Voriconazole | 9 | |
| 87116, 87206, 87556, 87798 | AFB Smear/Cult/AST/MTB Rifampin Resistance PCR,Non-Sputum | 1 | |
| 87899 | Candida Antigen | 1 | |
| 87328, 87329 | Giardia/Cryptosporidium EIA | 20 | |
| 87385 | Histoplasma Gal'mannan Ag Urine | 250 | |
| 87491, 87591 | Chlamydia/GC, NAA, confirmation | 1 | |
| 87116, 87206 | Acid Fast Smear + Culture w/ reflex ID | 600 | |
| 87149 | AFB ID by DNA Probe | 110 | |
| 87153 | Organism ID by Sequencing | 25 | |
| 87116; 87206 | Acid Fast Smear + Culture w/Reflex ID and susceptibility | 375 | |
| 87116, 87206, 87556 | AFB Identification DNA Probe | 4 | |
| 87149 | AFB ID+Susceptibilities | 15 | |
| 87305 | Aspergillus galactomannan Ag bronchial lavage or serum | 200 | |
| 87305 | Aspergillus galactomannan Ag csf | 1 | |
| 87081 | Carbapenem-resistant Enterobacteriaceae (CRE) Rectal Screen Culture | 7 | |
| 87493 | C difficile Toxin Gene NAA | 4 | |
| 87290 | Virus, Varicella Zoster Ag,DFA | 1 | |
| 87254(2) | Viral culture, Rapid, Influenza A and B | 1 | |
| 87254 | Viral Culture,Rapid,Varicella | 3 | |
| 87254 | Viral Culture, Rapid, CMV | 4 | |
| 87254, 87255 | Viral Culture,Rapid,Lesion | 1 | |
| 87804(2) | Influenza A+B Ag, EIA | 1 | |
| 87255 | HSV Culture Without Typing | 9 | |
| 87301, 87425 | Adenovirus (40/41)/Rotavirus | 1 | |
| 87661 | Trich vag by NAA | 2100 | |
| 87529(2) | HSV Types 1 and 2, NAA | 1 | |
| 87491 | Chlamydia trachomatis, NAA | 1 | |
| 87491 | Chlamydia, Conjunctiva, NAA | 1 | |
| 87591 | Neisseria gonorrhoeae, NAA | 5 | |
| 87329, 87177, 87209 | Giardia, EIA; Ova/Parasite | 1 | |
| 87070, 87278 | Legionella pneumophila/Culture | 82 | |
| 87101, 87206 | Fungus Culture With Stain (KOH/Calcofluor stain) | 475 | |
| 87205, 87070 | Gram Stain/Body Fluid Culture | 3 | |
| 87101 | Fungus Culture with Rapid ID | 1 | |
| 87169 | Scabies Examination | 1 | |
| 87168 | Parasite ID, Arthropod | 3 | |
| 87491, 87591 | Chlamydia/Gonococcus (CT/GC) NAA, Rectal | 40 | |
| 87491, 87591 | Chlamydia/Gonococcus (CT/GC) NAA, Pharyngeal | 50 | |
| 87591 | Neisseria gonorrhoeae/gonnoccus (GC) , NAA Rectal | 5 | |
| 87591 | Neisseria gonorrhoeae/gonnoccus (GC) NAA, Pharyngeal | 1 | |
| 88312 | P carinii Pneumonia, Stain | 2 | |
| 88142 | Pap Lb (Liquid-based) | 10 | |
| 88142 | Change IG Pap to LB Pap | 30 | |
| 87624, 88175 | IGP, high risk cobas w/ HPV genotypes 16/18 | 1 | |
| 88175 | Pap Test (Image-guided), Liquid-based With Reflex to HPV (Aptima®) When ASC-U | 14 | |
| 87624, 88175 | Pap Test (Image-guided), Liquid-based and HPV (Aptima®) With Reflex to HPV Genotypes 16 and 18,45 | 125 | |
| 87624, 88175 | Pap Test (Image-guided), Liquid-based and HPV (Aptima(R)) | 87 | |
| 88175 | Image Guided PAP,reflex Aptima HPV when ASC-U, with reflex to genotypes 16/18,45 | 30 | |
| 88175, 87624 | Pap Test (Image-guided), Liquid-based and HPV (Aptima®) With Reflex to HPV Genotypes 16 and 18,45 on high risk | 550 | |
| 88175 | Pap Test (Image-guided), Liquid-based With Reflex to HPV (Aptima®) When ASC-U, ASC-H, LSIL, HSIL, AGUS | 1 | |
| 82042, 82784 (x2), 82040 | IgG Index+Synthesis Rate | 4 | |
| 84220 | Pyruvate Kinase | 1 | |
| 82784, 82787(4) | IgG, Subclasses(1-4) | 90 | |
| 86645, 86694, 86762, 86778 | Prenat Infect Dis Ab, IgM, Qn | 1 | |
| 84490 | Fecal Chymotrypsin | 10 | |
| 86777, 86778 | Toxoplasma Antibodies IgG/IgM | 400 | |
| 82172 (2) | Apo Assessment (A1 + B + Ratio) | 9 | |
| 86663, 86664, 86665(2) | Epstein-Barr Acute Infection Antibodies | 6 | |
| 82164 | Angiotensin Convert Enz., CSF | 1 | |
| 80061 | Lipid Panel w/ Chol/HDL Ratio | 1 | |
| 86644, 86645 | CMV Antibodies, IgG/IgM | 1 | |
| 86160 | Complement Component 7 | 1 | |
| 84439, 84443 | TSH + Free T4 | 1 | |
| 80061 | Lipid Panel With LDL/HDL Ratio | 1 | |
| 80061, 83700 | Lipoprotein Phenotyping | 1 | |
| 86704, 86705, 86706, 87340 | HBV Prevaccination (Profile X -HBsAg, Anti-HBs, Anti-HBc, total, Anti-HBc-IgM) | 1 | |
| 86787 (x2) | Varicella Zoster Abs, IgG/IgM | 1 | |
| 83001 | Follicle Stimulating Hormone, All genders (ranges established & reported for all genders) | 5 | |
| 86664, 86665 X2 | Epstein-Barr Virus (EBV) Antibody Profile | 440 | |
| 84311 | Cholesterol, Fluid | 25 | |
| 86727 | Lynphocytic Choriomeningitis (LCM) Virus, IgG | 3 | |
| 822175, 82300, 82570, 83655, 83825 | Heavy Metals Profile II, Urine (Arsenic (Total) reflex to inorganic Arsenic, cadmium, lead, mercury) | 5 | |
| 81405 | α-Galactosidase A Deficiency (GLA) full gene Sequencing | 1 | |
| 81215 | BRCA1 Targeted Sequencing | 1 | |
| 81404 | VHL (von Hippel-Lindau Disease) Full Gene Analysis | 1 | |
| 81404 | Beta-Thalassemia: HBB (Full sequencing) | 1 | |
| 81222 | Cystic Fibrosis (CF) CFTR Deletion/Duplication Analysis | 1 | |
| 81211, 81213 | BRCA 1/2 Comprehensive Analysis | 5 | |
| 86357, 86359, 86360 | Helper/Suppress/Natural Killer | 2 | |
| 86706 | HBV Vaccine Follow-Up (Pro XI) | 3 | |
| 82747, 85014 | Folate, RBC | 120 | |
| 80299 | Propafenone (Rythmol) | 1 | |
| N/A | Stat Service (Stat Processing/Testing) | 68 | |
| 86609 | Listeria Abs, CSF | 1 | |
| 86160 | Complement Component 9 | 1 | |
| 85302, 85303 | Protein C Deficiency Profile | 40 | |
| 83519 | Substance P | 1 | |
| 85557 | Osmotic Fragility Erythrocyte | 2 | |
| 84311 | Fungitell, Serum | 400 | |
| 82384, 84585 | Catecholamine+VMA, 24-Hr Urine | 10 | |
| 80061 | Lipid Panel | 1 | |
| 81003, 82131, 82140, 82340, 82436, 82507, 82570, 83735, 83935, 83945, 84105, 84133, 84300, 84392, 84560 | Kidney Stone, Urine/Saturation | 80 | |
| 86631(3). 86632(3) | Chlamydia Species Ab Panel IgG/IgM | 1 | |
| 82042 | Albumin, Body Fluid | 200 | |
| 82384, 82570 | Catecholamines,Urinary Free,Random | 15 | |
| 83497, 82570 | 5-HIAA Qn,Random Urine | 5 | |
| 80053 | Comp. Metabolic Panel (14) | 3 | |
| 80074 | Hepatitis Panel , Acute (Hep A Antibody, IgM; Hep B Core, IgM; HBsAg; HCV) | 1 | |
| 80048 | Basic Metabolic panel (8) | 1 | |
| 82784, 83516(2) | Celiac Disease Antibody Screen (Deamidated gliadin IgA; tissue transglutaminase IgA; serum qunatitation) | 1 | |
| 86632(3) | Chlamydia Species Ab Panel IgM | 1 | |
| 84166, 84156 | Protein Electrophoresis, Random Urine | 20 | |
| 82657 | Alpha-Galactosidase A deficiency, leukocytes | 2 | |
| 82657 | Arylsulfatase A Deficiency | 1 | |
| 81220 | Cystic Fibrosis Profile 97 Mutations CF Plus | 1 |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .